3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
5
Triple Negative Breast Neoplasms
3
Neoplasms
3
Neoplasm Metastasis
3
Uterine Cervical Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Camurati-Engelmann Syndrome
2
Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Microsatellite Instability
1
Metastatic Solid Tumors
1
Mesothelioma, Malignant
1
Mesothelioma
1
Melanoma
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Gallbladder Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Brain Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
pembrolizumab
2
fludarabine phosphate
2
fludarabine
2
aldesleukin
2
Cyclophosphamide
2
rocakinogene sifuplasmid
1
durvalumab
1
VGX-3100
1
Surveys and Questionnaires
1
Sildenafil Citrate
1
Paclitaxel
1
MEDI0457
1
Interleukin-2
1
Immunoglobulin G
1
Ifosfamide
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Fentanyl
1
Disulfides
1
Cisplatin
1
Alprostadil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Penile Neoplasms
×
bintrafusp alfa protein, human
×
Clear all
No trials found.